2BB score and signals
iBio, Inc.’s current 2BB score is 32 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 33 | Low |
| Momentum | 73 | Improving |
| Financial strength | 23 | Weak |
| Quality | 36 | Weak |
| Risk | 53 | Moderate |
2BBBullish & Bearish
iBio, Inc. (IBIO) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 32 out of 100.
iBio, Inc.’s current 2BB score is 32 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 33 | Low |
| Momentum | 73 | Improving |
| Financial strength | 23 | Weak |
| Quality | 36 | Weak |
| Risk | 53 | Moderate |
| Founded | 2008 |
| Employees | 23 |
| 52-week range | $0.73 – $3.82 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-08 | — | -0.0877 | — | $0.00 |
| 2026-11-10 | — | -0.0734 | — | $20,400.00 |
| 2026-09-03 | — | -0.065 | — | $58,282.00 |
| 2026-05-12 | -0.07 | -0.0639 | $0.00 | $20,400.00 |